Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806870 · ClinicalTrials.gov registry record · NA
Immune Enhancement for Immunological Non-responders to ART
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01806870 is a NA study that has completed, run by Emory University. The registered enrollment target is 30 participants.
The verdict
NCT01806870, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to see if taking two nutritional supplements, zinc and SAMe (S-adenosylmethionine), can improve lung health and immune function in persons with HIV. You are being asked to volunteer because you have HIV (Human Immunodeficiency Virus) and you take anti-retroviral therapy (ART) medications.
Interventions
- DIETARY_SUPPLEMENT Zinc and SAMe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01806870
The ClinicalTrials.gov registry entry for NCT01806870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zinc and SAMe is the first listed.
NCT01806870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01806870 about?
NCT01806870 is a clinical study titled "Immune Enhancement for Immunological Non-responders to ART". The purpose of this study is to see if taking two nutritional supplements, zinc and SAMe (S-adenosylmethionine), can improve lung health and immune function in persons with HIV. You are being asked to volunteer because you have HIV (Human Immunodeficiency Virus) and you take anti-retroviral therapy ...
What is the current status of trial NCT01806870?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-03. Estimated completion is 2018-12-15.
What interventions are being tested in trial NCT01806870?
The interventions under investigation include: Zinc and SAMe (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01806870?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.